Clinical Trial Update: Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for a measles, mumps and rubella combined live vaccine; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunotoxicity
• Vaccine

Drugs mentioned

• Measles, Mumps and Rubella Combined Vaccine, Live

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Immunotoxicity, Vaccine | Phase 4 | Status: COMPLETED